Oppenheimer (OPY)
Oppenheimer R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
OPY R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.00 | Jun 2007 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these OPY related companies
OPY News
Paul Vasilopoulos Joins Oppenheimer's Investment Banking Group As Managing Director - Head Of Telecom
May 17, 8:50AM PR Newswire
May 17, 8:50AM PR Newswire
John Stoltzfus Named Managing Director And Chief Market Strategist At Oppenheimer
May 07, 5:00AM PR Newswire
May 07, 5:00AM PR Newswire
$OPY forms bearish "Diamond Top" chart pattern. http://stks.co/3fMr
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
Oppenheimer's Equity Research Group Adds Brian Schwartz As Managing Director For SaaS/Applications Software
Apr 30, 11:35AM PR Newswire
Apr 30, 11:35AM PR Newswire
Gordon Morse Joins Oppenheimer As Managing Director -- Investments And Branch Manager Of Atlanta, GA Office
Apr 25, 8:00AM PR Newswire
Apr 25, 8:00AM PR Newswire
$OPY filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/38Zp
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
Oppenheimer's Institutional Equity Derivatives Team Builds Out Options Desk With 3 Senior Professionals
Mar 23, 12:13PM PR Newswire
Mar 23, 12:13PM PR Newswire
Oppenheimer's 6th Annual China Dragon Conference Provides Hands-on Meetings With Thriving Companies
Mar 16, 3:02PM PR Newswire
Mar 16, 3:02PM PR Newswire
There's a lot of shady stuff going on out there lately, but a potentially mistaken $4M overstatement in a fund by $OPY is so small potatoes.
about 78 days ago by bradloncar
about 78 days ago by bradloncar
$OPY forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2eRB
about 90 days ago by RecogniaEvents
about 90 days ago by RecogniaEvents
$OPY forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2eHU
about 90 days ago by RecogniaEvents
about 90 days ago by RecogniaEvents
$OPY forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2dsh
about 91 days ago by RecogniaEventsTest
about 91 days ago by RecogniaEventsTest
URGENT: $OPY filed to delay releasing quarterly earnings results (SEC Filing Form NT 10Q) http://stks.co/14sH
about 203 days ago by MarketBrief
about 203 days ago by MarketBrief
Today's Dividend-Paying Winners and Losers: http://stks.co/13bt / $NP $DMND $WTW 4HSC $OPY $CSC
about 204 days ago by DynamicDividend
about 204 days ago by DynamicDividend
$OPY Oppenheimer Holdings Inc. Announces Stock Repurchase Program of 650k Shares
about 237 days ago by Benzinga
about 237 days ago by Benzinga
RT @EddyElfenbein Oppenheimer downgrades $BBBY. In turn, I downgrade Oppenheimer $OPY
about 450 days ago by howardlindzon
about 450 days ago by howardlindzon
$OPY, $WFC, $SCH - Latest Target of ARS Sellers Is Government Bailout Money - Scandal with a Long Tail - http://tinyurl.com/mxbmrr
about 1030 days ago by Ro_Patel
about 1030 days ago by Ro_Patel
$OPY returned to profitability in Q2; still think earnings power is $6-7 per share and growing; at $29, the stock is 4x to 5x earnings power
about 1035 days ago by gatorcapital
about 1035 days ago by gatorcapital
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OPY | 14.00 | +0.03 | +0.21% | 189.85M |
| OPXT | 1.04 | -0.01 | -0.95% | 94.82M |
| OPXA | 0.4725 | +0.00 | +0.51% | 10.84M |
| OPWV | 2.92 | +0.00 | +0.00% | 250.48M |
| OPTT | 2.12 | -0.04 | -1.85% | 22.49M |
| OPTR | 14.95 | -0.18 | -1.19% | 707.33M |
| OPNT | 24.96 | -0.68 | -2.65% | 578.44M |
| OPLK | 12.81 | +0.14 | +1.10% | 243.52M |
| OPHC | 0.6402 | -0.02 | -3.29% | 14.65M |
| OPEN | 39.64 | +0.00 | +0.00% | 893.88M |
